Premium
Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft‐tissue sarcomas in 39 dogs
Author(s) -
Simon D.,
Ruslander D. M.,
Rassnick K. M.,
Wood C. A.,
Frimberger A. E.,
Cotter S. M.,
King N. W.,
Moore A. S.
Publication year - 2007
Publication title -
veterinary record
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 99
eISSN - 2042-7670
pISSN - 0042-4900
DOI - 10.1136/vr.160.10.321
Subject(s) - soft tissue , doxorubicin , medicine , radiation therapy , radiology , surgery , chemotherapy
The efficacy and toxicity of orthovoltage radiation therapy and concurrent low doses of doxorubicin for the treatment of incompletely excised soft‐tissue sarcomas in 39 dogs was investigated retrospectively. The 39 dogs had 40 soft‐tissue sarcomas and received 51 Gy orthovoltage radiation in 17 daily 3 Gy fractions; they also received 10 mg/m 2 doxorubicin once a week administered intravenously one hour before the dose of radiation. The median follow‐up time was 910 days. The tumours recurred locally in seven of the dogs, in five of them within the radiation field; the median time to their recurrence was 213 days (range 63 to 555 days). Six of the dogs developed a distant metastasis after a median time of 276 days (range eight to 826 days). The one‐year and two‐ to four‐year tumour control rates were 84 per cent and 81 per cent, respectively, and the one‐, two‐ and three‐ to four‐year survival rates were 85 per cent, 79 per cent and 72 per cent, respectively. Tumours with a mitotic rate of more than 9 per 10 high‐power fields were significantly more likely to recur, and the dogs with such tumours survived for significantly shorter periods.